Abstract
Background: Reaction of α,β-unsaturated ketones with o-phenylenediamine afforded corresponding 2,3-dihydro-1H-1,5-benzodiazepines.
Objective: α,β-Unsaturated ketones of 6-acetyl-5-hydroxy-4-methylcoumarin are precursors for synthesis of 2,3-dihydro-1H-1,5-benzodiazepines by a reaction with o-phenylenediamine.
Methods: Enones of 6-acetyl-5-hydroxy-4-methylcoumarin were prepared from this ketone and (un)substituted benzaldehydes in the presence of piperidine, triethylamine, or pyridine as a catalyst in absolute ethanol with 1:1 molar ratios, respectively. 2',3'-Dihydro-1H-1',5'-benzodiazepines were synthesized by using the reaction of these enones with o-phenylenediamine in absolute ethanol in the presence of glacial acetic acid as a catalyst. Their biological activities were evaluated using the disk diffusion method.
Results: Seven new 2',3'-dihydro-1H-1',5'-benzodiazepines were obtained and their structures were confirmed by thin-layer chromatography, IR, NMR and MS spectra. Some synthesized benzodiazepines showed antibacterial and antifungal activities against Escherichia coli (Gram-(−) bacterium), Staphylococus epidermidis (Gram-(+) bacterium). Candida albicans (fungus).
Conclusion: The formation of enones from 6-acetyl-5-hydroxy-4-methylcoumarin and (un)substituted benzaldehydes could be catalyzed by piperidine, triethylamine, pyridine to afford similar yields. 2',3'-dihydro-1H- 1',5'-benzodiazepines have been synthesized from the aforementioned enones and o-phenylenediamine.
Keywords: Benzodiazepines, chromene, ethyl acetoacetate, 3-acetylcoumarin, o-phenylenediamine, α, β-unsaturated ketones.
Graphical Abstract
[http://dx.doi.org/10.1016/j.molstruc.2016.07.047]
[http://dx.doi.org/10.1016/j.cclet.2009.01.003]
[http://dx.doi.org/10.1039/C5OB00655D] [PMID: 25875695]
[http://dx.doi.org/10.1016/j.ejmech.2010.01.001] [PMID: 20163892]
[http://dx.doi.org/10.1002/da.22643] [PMID: 28504861]
[http://dx.doi.org/10.1038/s41380-018-0310-3] [PMID: 30504824]
[http://dx.doi.org/10.1016/j.mpmed.2016.09.019]
[PMID: 12608009]
[http://dx.doi.org/10.1093/jac/dku034] [PMID: 24535279]
[http://dx.doi.org/10.1080/10426501003713064]
[http://dx.doi.org/10.1155/2019/9043570]
[http://dx.doi.org/10.1021/jm100739n] [PMID: 21049954]
[http://dx.doi.org/10.1002/14651858.CD008922.pub2]
[http://dx.doi.org/10.1016/S0223-5234(01)01283-1] [PMID: 11755236]
[http://dx.doi.org/10.1007/s12039-013-0412-z]
[http://dx.doi.org/10.1039/C3GC41898G]
[http://dx.doi.org/10.1016/j.tetlet.2011.06.029]
[http://dx.doi.org/10.1002/cber.19590921138]
[http://dx.doi.org/10.1016/j.jfluchem.2013.03.023]
[http://dx.doi.org/10.3987/R-1986-01-0135]
[http://dx.doi.org/10.1039/p19740002657]
[http://dx.doi.org/10.1080/00397919908086183]
[http://dx.doi.org/10.1016/S0040-4039(02)00115-6]
[http://dx.doi.org/10.4172/pharmaceutical-sciences.1000335]
[http://dx.doi.org/10.1007/BF00474444]
[http://dx.doi.org/10.1016/j.mimet.2019.105765] [PMID: 31676421]
[http://dx.doi.org/10.1016/j.jgar.2018.05.009] [PMID: 29782954]